Seres Therapeutics, Inc.MCRBNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
885.04%
↑ 1702% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthStrong
Average
-55.23%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 885.04% | - |
| 2024 | 0.00% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | +100.0% |
| 2021 | -39.14% | +83.2% |
| 2020 | -232.76% | -29.2% |
| 2019 | -180.19% | +44.1% |
| 2018 | -322.21% | -25.9% |
| 2017 | -255.83% | +37.2% |
| 2016 | -407.21% | - |